Search result for Karuna
U.S IPO Karuna Therapeutics gives huge returns to investors
Karuna Therapeutics is a state-of-the-art clinical-stage biopharmaceutical company mainly focused on developing original therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.
As the company performed well in November month, the early...
Since its debut with Karuna, biopharma has stockpiled up 26% on average
Boston-based Karuna Therapeutics Inc. has earned the distinction of the best IPO performer so far in 2019 with a stock price rise of 349% as of its launch in June on the U.S. markets.
Following the positive Phase II high-line data from Karxt in acute psychosis in Schizophrenic patients ...